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ABSTRACT 
One of the important diagnostic modalities in cardiology is cardiac catheterization, which is one 
tool for myocardial revascularization. This examination is particularly useful in the aspect of 
cardiac hemodynamic evaluation, among other utilities. This review describes the advance of 
cardiac catheterization from the beginning of its discovery to future development.
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INTISARI
Salah satu modalitas diagnostik penting dalam kardiologi adalah kateterisasi jantung, yang 
merupakan salah satu cara revaskularisasi miokard. Pemeriksaan ini terutama berguna 
dalam aspek evaluasi hemodinamik jantung, diantara kegunaan yang lain. Tinjauan pustaka 
ini menerangkan perkembangan kateterisasi jantung dari awal mula penemuannya sampai 
perkembangan di masa depan. 
BACKGROUND
One of the important diagnostic modalities 
in cardiology is cardiac catheterization. This 
examination is particularly useful in the aspect 
of hemodynamic evaluation that is to measure 
intra-cardiac pressure, blood saturation of the 
heart chambers, and cardiac output. Cardiac 
catheterization is one of the greatest discoveries 
in the field of cardiology in the 20th century.
DISCUSSION
History of Cardiac Catheterization
The history of cardiac catheterization, 
angioplasty, and other catheter interventions is a 
remarkable journey and takes a long time. Around 
four hundred years has been passed to gradually 
change the method of cardiac catheterization 
until it finally becomes as advanced as it is today. 
One major step that started this development 
was the discovery of a description of the human 
blood circulation by a British physician named 
William Harvey in 1628. Then, in 1706 Raymond 
de Vieussens, an anatomical professor from 
France for the first time described the structure 
of chambers and blood vessels of the heart. 
Furthermore, Stephen Hales, a British priest and 
scientist in 1711 performed a biventricular heart 
catheterization on a horse. More or less a century 
after Harvey’s monumental discovery, Hales for 
the first time measured arterial blood pressure 
that became the next important milestone in 
the history of cardiac catheterization. Harvey 
and Hales became the main characters on two 
important moments that became milestones on 
the development of cardiac catheterization. Hales 
concrete steps followed other catheterization 
experimental procedures in the 19th century. 
90  
Setianto, 2018
Claude Bernard in 1844 used a catheter to 
record intra-cardiac pressure in animals. He 
is a renowned physiologist from France who 
coined the term cardiac catheterization. Claude 
Bernard’s scientific achievements with other 
scientists, such as Carl Ludwig and Etienne-Jules 
Marey, were the golden age of cardiovascular 
physiology at that time.1
The catheterization of the human heart 
grew in the twentieth century. A dramatic action 
by Werner Forssmann, a surgical resident in 
1929 at Eberswald Germany, who performed 
right heart catheterization on himself. This action 
is the first recorded catheterization in humans, 
which is anesthetized his left elbow, inserting a 
catheter into the antecubital vein and positioning 
the catheter tip in the right atrium using an x-ray. 
The original goal was to find an effective and safe 
pathway to include cardiac resuscitation drugs. 
Forssmann then developed his experiment 
toward intra-cardiac contrast media injection 
via a catheter placed in the right atrium. Such 
contributions, together with the development 
of nontoxic contrast media and radiological 
techniques, have paved the way for the 
development of coronary angiography. A decade 
after the phenomenal and therapeutic-oriented 
Forsmann catheterization, the first diagnostic 
cardiac catheterization by André Cournand and 
Dickinson Richards was introduced in 1941. They 
used cardiac catheters for diagnostic purposes 
to measure right heart and cardiac output. For 
their hard work, Forssmann, Cournand, and 
Richards were awarded the Nobel Prize in 
Medicine in 1956. In the 1950s, Zimmerman, 
Cope, Ross, and other scientists succeed to 
explore the left heart with a catheter. The first 
selective coronary arteriography in 1958 was 
introduced by Mason Sones. He performed this 
action on more than a thousand patients. A brief 
description of his technique was published in 
Modern Concepts of Cardiovascular Diseases 
in 1962. This development became the opening 
gate of a period of rapid advancement in aspects 
of coronary arteriography during the mid-1960s.2
The recanalization of peripheral arteries 
by catheters by accident by Charlod Theodore 
Dotter in 1963, further asserted the beginning 
of the intervening era. Dotter actually wanted 
to do an abdominal aortogram in a patient with 
renal artery stenosis by inserting a catheter 
percutaneously through a retrograde pathway. 
This catheter passes through the right iliac artery 
that is occluded, causing the artery to undergo 
a recanalization. Sones and Dotter’s actions 
were followed by the percutaneous coronary 
femoral angiography method popularized by 
Melvin Judkins and Amplatz in 1967. Judkins 
was a radiologist who had studied coronary 
angiography with Sones. That year, Judkins 
created a coronary imaging system, introduced 
special catheters, and perfected the transfemoral 
approach. A more recent technique, angioplasty 
with balloons, was introduced by Andreas 
Gruentzig in the mid-1970s. Gruentzig also 
pioneered other catheter-based interventions 
during the decade. His pioneering has made 
significant progress in the improvement and 
development of catheterization techniques.3
At present, coronary angiography and 
percutaneous coronary intervention are 
performed primarily by the approach of radial 
arteries and femoral arteries. Sones technique 
is rarely used again. The discovery of Sones, 
Dotter, and Gruentzig above has led us to 
an era of well-equipped weapons of arterial 
revascularization equipment used for various 
clinical conditions. Beyond the domain of 
intervention, another historic momentum in 
cardiology was born in the early decades of 
the twentieth century, precisely in 1912, where 
cardiovascular disease caused by hardening of 
the arteries was first described by an American 
physician named James B. Herrick. Meanwhile, 
the discovery of X-rays by Wilhelm Roentgen in 
1895 enabled the study of cardiac anatomy to be 
91  
Acta Cardiologia Indonesiana (Vol 3 No. 2): 89-93
carried out with this new approach. The discovery 
of X-rays was followed by the appearance of the 
first human radiographic coronary artery atlas 
in 1907. This atlas was created and published 
by two German doctors, Friedrich Jamin and 
Hermann Merkel. This development in the 
theoretical aspects of cardiology and radiology 
indirectly also influences developments in 
aspects of interventional cardiology.4
Clinical Benefits
The emergence of this great cardiologic 
discovery has helped solve cardiovascular 
problems. Cardiac catheterization can be applied 
to see the condition of coronary artery (coronary 
angiography) or right heart catheterization. Based 
on the executive summary of the guidelines for 
coronary angiography from the American College 
of Cardiology / American Heart Association (ACC 
/ AHA), this modality is used to:
1. Coronary artery disease that is known or 
newly suspected,
2. Valvular heart disease
3. Congenital heart disease
4. Congestive heart failure
5. Other conditions (i.e. diseases involving the 
aorta and hypertrophic cardiomyopathy).
Especially for coronary artery disease, 
coronary angiography is a standard criterion 
for diagnosis and is a primary method to help 
illustrate the anatomy of coronary arteries. 
Patients with known or suspected coronary artery 
disease may be stable angina, nonspecific chest 
pain, unstable angina, recurrent ischemia after 
revascularization, acute myocardial infarction, and 
in perioperative periods of non-cardiac surgery, 
usually recommended coronary angiography 
(i.e. with recommendation class I) if noninvasive 
examination results indicate a high risk, having a 
Canadian Cardiovascular Society III-IV class and 
undergoing medical therapy, suspected subsequent 
closure or subacute stromal thrombosis following 
percutaneous revascularization, or other important 
conditions. The use of right heart catheterization 
has several benefits:
1. To diagnose patients with congenital heart 
disease and obtain.
2. To monitor ICU patients with cardiovascular 
disease.
Table 1.Stenting unprotected left main coronary artery with drug eluting stents
(Table source: Park et al., 2005)6
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3. When placed in the right auricular proximal, 
the catheter can be an important and safe 
route for administration of fluids, medications, 
and parenteral nutrition.
4. For physiological studies of cardiovascular 
dynamics in both normal individuals and 
patients with heart disease.
Current Developments
More than 70 years since Forsmann’s 
phenomenal action, percutaneous coronary 
intervention has shifted the position of coronary 
artery bypass surgery to become a more 
common procedure in many countries. Includes 
stent implantation on unprotected left main 
disease, which was always indicated bypass 
operation. (Table 1.)6
The frequency of its implementation 
continues to grow. The success rate is over 95% 
with the risk of serious complications declining. 
Patients can be mobilized immediately and 
discharged on the same day or the next day. 
The recurrent stenosis that becomes a scourge 
now slowly begins to diminish. The success of 
percutaneous intervention is closely related to 
the developments, such as:
1. Improved quality of intra-coronary and 
balloon guide wire thus enhancing the level 
of safety and effectiveness.
2. Increased diversity of balloons, stents, and 
other devices mounted with the help of a 
catheter.
3. Replace the contrast media used.
Progress is the fastest in terms of stent 
development. These stents are made of stainless 
steel tubes and have different strength and 
flexibility. After being cut using laser light, the 
tubes are shaped into a variety of stent designs. 
They are chemically scratched, electroplated 
into fine final results, and sometimes coated. We 
have available various types of stent. There are 
regular stents that do not contain drugs called 
bare-metal stents (BMS). This BMS discovery 
was the second revolution in the world of 
interventional cardiology after the first revolution 
by Gruentzig. The risk of restenosis (occurrence 
that occurs after stent implantation) due to tissue 
growth has led to the emergence of another 
stent variance drug-eluting stent (DES). This 
stent contains drugs to prevent or delay tissue 
proliferation. Its use has reduced the incidence 
of stenosis again compared to the use of BMS. 
This was first observed in the RAVEL study, a 
randomized study comparing stent containing 
sirolimus with standard stent. Stent, in particular 
DES, reduces the risk of restenosis but is also 
associated with other risks of stent thrombosis. 
Therefore, dual anti-platelet therapy (DAPT) is 
necessary for patients who use it.
The development of the next stent 
considered the fourth revolution is the invention 
of bioresorbable vascular scaffold (BVS). This 
technology allows temporary scaffolding of the 
blood vessels to prevent acute closure. Anti-
proliferation drugs are temporarily elaborated 
to overcome the constrictive remodeling and 
hyperplasia of excessive intima layers. One of 
the advantages of this invention is the reduction 
in the side effects of stent thrombosis. In addition, 
scaffolding is only temporary until the blood 
vessels heal. No foreign matter is a potential 
trigger for stent thrombosis (such as non-
endothelial strut and drug polymer) that persists 
for a long time. 
Other advances achieved are in terms 
of contrast media and the application of digital 
technology to angiography. Early in its appearance, 
the angioplasty procedure used a toxic contrast 
medium. Relatively safe contrast media has 
now replaced it. The digital angiography system 
is a major advance that goes beyond the old 
cine-based systems.In addition to aspects 
of coronary intervention, the development of 
cardiac catheterization also penetrated aspects of 
cardiovascular critical care. 
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Right heart catheterization has developed 
into pulmonary artery catheterization. This 
examination was first introduced to the intensive 
care unit about 40 years ago. Despite the lack of 
evidence demonstrated by controlled randomized 
studies of its clinical utility, pulmonary artery 
catheterization has become the standard of care 
for patients with critical illness.5
CONCLUSION
Coronary revascularization begins with 
the description of the human blood circulation, 
then followed by a picture of the structure of 
the chamber and blood vessels of the heart. 
Furthermore, coronary angiography in animal 
models, initiates angiography procedures in 
humans. Percutaneous coronary intervention 
(PCI) is currently highly advanced from 
angioplasty to stent implantation, from BMS to 
BVS. Along with the development of non-toxic 
contrast media security and various devices 
for implantation of stent, shifting the bypass of 
coronary arteries by PCI and its use is more 
prominent in many countries. The advancement 
of today’s digital angiography system extends 
beyond the old cine-based systems. In addition, 
cardiac catheterization is often used in critical 
cardiovascular care.
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